CCHE Seminar Series: Health Technology Assessment in Canada
Health Technology Assessment in Canada
Canadian Agency for Drugs and Technology in Health, University of Toronto
Friday November 25, 2022, 10am-12pm, via Zoom
Abstract: This will be a “hybrid” presentation. Hybrid in terms of two topics, namely research and impact. The first part of the session will discuss costing work using administrative databases. The second part of the session will examine the process and structure for health technology assessment in Canada.
Dr. Nicole Mittmann is CADTH’s Chief Scientist and Vice-President of Evidence Standards. Dr. Mittmann holds an MSc and PhD in pharmacology from the University of Toronto. She holds a faculty position as an assistant professor at the University of Toronto in the Department of Pharmacology & Toxicology; and is cross-appointed to the Institute for Health Policy, Management and Evaluation. She is also an associate scientist at Sunnybrook Health Sciences Centre in Toronto, Canada. In her Chief Scientist role, Dr. Mittmann is responsible for ensuring that CADTH actively learns, ensures rigour and quality, mobilizes evidence, and links science to strategy. In her Evidence Standards role, Dr. Mittmann leads CADTH’s shared science groups, including the Health Economics, Research Information Services, Scientific Affairs, Implementation Support and Knowledge Mobilization, and Real-World Evidence teams. In her academic capacity, Dr. Mittmann has conducted and collaborated on notable research in the areas of economic evaluations, outcomes research, and drug/patient safety. Research methodologies include the examination of large databases, economic methodologies, and decision analysis.